BlackRock increased its holdings in China National Pharmaceutical Group (01099.HK) by 1.1016 million shares at a price of approximately HK$21.28 per share.

According to the Zhitong financial APP, Hong Kong Stock Exchange's latest data shows that on November 12th, BlackRock increased its holdings of China Resources Pharmaceutical Group (01099.HK) by 1.1016 million shares, with a price of 21.2787 Hong Kong dollars per share, totaling approximately 23.4406 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 67.9278 million shares, with the latest shareholding ratio being 5.06%.